Skip to main content

Table 2 The associations of 11 genes with disease-free survival (DFS) and/or overall survival (OS) of patients with hepatocellular carcinoma in a TCGA cohort, analysed using Kaplan-Meier survival plots

From: Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma

 

DFS (Median)

OS (Median)

  

95 % Confidence Interval

  

95 % Confidence Interval

Estimate

Std. Error

Lower Boundary

Upper Boundary

Estimate

Std. Error

Lower Boundary

Upper Boundary

ACSM3

H

24.800

7.587

9.930

39.670

    
 

L

14.400

2.391

9.714

19.086

    
 

Overall

19.300

3.428

12.581

26.019

    

CXCL14

H

29.300

10.355

9.004

49.596

    
 

L

16.400

2.222

12.045

20.755

    
 

Overall

19.300

3.428

12.581

26.019

    

INTS8

H

14.400

2.408

9.681

19.119

21.700

5.048

11.805

31.595

 

L

27.200

4.266

18.839

35.561

53.300

10.531

32.659

73.941

 

Overall

19.300

3.428

12.581

26.019

37.800

8.792

20.568

55.032

LCAT

H

29.300

5.287

18.937

39.663

55.600

13.029

30.063

81.137

 

L

14.800

2.129

10.628

18.972

21.700

5.133

11.640

31.760

 

Overall

19.300

3.428

12.581

26.019

37.800

8.792

20.568

55.032

MARCO

H

24.800

6.094

12.856

36.744

53.300

16.525

20.911

85.689

 

L

15.600

1.710

12.248

18.952

23.300

5.664

12.199

34.401

 

Overall

19.300

3.428

12.581

26.019

37.800

8.792

20.568

55.032

PAMR1

H

29.300

7.881

13.853

44.747

69.500

7.445

54.908

84.092

 

L

16.400

3.616

9.312

23.488

21.100

1.762

17.647

24.553

 

Overall

19.300

3.428

12.581

26.019

37.800

8.792

20.568

55.032

CRHBP

H

    

55.600

13.080

29.964

81.236

 

L

    

27.500

7.523

12.754

42.246

 

Overall

    

37.800

8.792

20.568

55.032

DNASE1L3

H

    

55.600

6.310

43.232

67.968

 

L

    

23.300

5.103

13.298

33.302

 

Overall

    

37.800

8.792

20.568

55.032

FCN2

H

    

53.300

12.677

28.453

78.147

 

L

    

30.600

10.341

10.331

50.869

 

Overall

    

37.800

8.792

20.568

55.032

MT1X

H

    

58.800

12.301

34.690

82.910

 

L

    

23.300

5.997

11.546

35.054

 

Overall

    

37.800

8.792

20.568

55.032

VIPR1

H

    

51.300

7.615

36.374

66.226

 

L

    

20.600

5.643

9.540

31.660

 

Overall

    

37.800

8.792

20.568

55.032

  1. The gene expression and survival data of 157 HCC patients in a TCGA cohort were used for the analysis. Expression values of a gene were dichotomised into high and low expression using the median as a cutoff
  2. H high expression, L low expression